A previously unknown protein in a family of bacteria found in soil and the human gut microbiome has been discovered—which ...

The dose of paclitaxel used in the new approach was 16-fold lower than that typically used in free paclitaxel, but with similar efficacy.

Southside Cancer Care Centre in Miranda initiated as first site for Race’s Phase I trial of cardioprotective therapy RC220 in ...

The new drug development corporation Daimbio announced on the 25th that it has completed a series A funding round worth 12 ...

The battle against drug resistance in lung cancer therapy remains a critical issue in oncology, with resistance mechanisms ...

South Korean biotechnology firm SillaJen Inc. is pioneering a new approach to determine the best dose for a cancer drug ...

Successful treatment of severe lung cancer caused by third-generation EGFR-TKI resistance due to EGFR genotype conversion with afatinib plus anlotinib. Complete response of recurrent perihilar ...

Innovative technologies such as artificial intelligence (AI), machine learning, and quantum computing can accelerate the design and discovery of novel drugs ... can create anti-cancer molecules ...

These cancers are, however, quite sensitive to anticancer drugs such as poly (ADP-ribose) polymerase inhibitors (PARPi). When successful, these cancer treatments cause enough DNA damage to trigger ...

During her doctoral program at UTEP, Villanueva conducted much of the research that led to the discovery of pyronaridine as an anti-cancer drug. "It's incredible to witness the hard work invested ...

PhD Defense: Advancing Therapeutic Drug Monitoring of oral targeted anticancer drugs; analytical and clinical studies ...